focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,364.00
Bid: 12,398.00
Ask: 12,400.00
Change: 268.00 (2.22%)
Spread: 2.00 (0.016%)
Open: 12,150.00
High: 12,440.00
Low: 12,134.00
Prev. Close: 12,096.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET CLOSE: Risk-off mood prevails but FTSE 100 outperforms

Wed, 05th Apr 2023 17:01

(Alliance News) - Stocks in London closed largely lower on Wednesday, while the FTSE 100 ended in the green thanks to a solid performance from utility and pharmaceutical stocks.

"Appetite for risk is slowly decreasing, taking a break from the sharp bull run that started last week, while investors wait for further macro developments," said Pierre Veyret at ActivTrades.

The FTSE 100 index closed up 28.42 points, or 0.4% at 7,662.94 on Wednesday. Meanwhile, the FTSE 250 ended down 213.62 points, or 1.1%, at 18,601.42, and the AIM All-Share closed down 6.53 points, or 0.8%, at 803.69.

The Cboe UK 100 ended up 0.2% at 765.65, the Cboe UK 250 closed down 1.8% at 16,137.00, and the Cboe Small Companies ended marginally lower at 13,349.60.

The pound was quoted at USD1.2471 at the London equities close Wednesday, down from USD1.2501 at the close on Tuesday.

In the FTSE 100, RS Group dropped 6.2%, making it the worst blue-chip performer at the close on Wednesday.

For the year ended March 31, the industrial and electronics products distributor said it saw 10% like-for-like revenue growth. For the fourth quarter alone, group like-for-like revenue improved 1% on-year, but slowed from 8% growth in the third quarter.

Consequently, Chief Financial Officer David Egan said that the firm anticipates full year adjusted operating profit to be "slightly ahead of consensus expectations."

RS said adjusted operating profit consensus stands at GBP382.0 million, which, if achieved, would represent growth of 19% from GBP320.4 million the prior year.

AstraZeneca climbed 2.8% after it announced it received positive results from interim analysis of the DUO-O phase 3 trial of its Imfinzi drug.

The pharmaceutical company said the analysis showed that a combination of Imfinzi, alongside Lynparza, chemotherapy and bevacizumab met its primary endpoint.

It showed a "statistically significant and clinically meaningful" improvement in progression-free survival when compared with treatment with just chemotherapy and bevacizumab.

Pharmaceutical peers Haleon and GSK both rose 2.5% in a positive read-across.

Also near the top of London's flagship index were United Utilities, National Grid, Centrica and Severn Trent which closed 3.2%, 2.2%, 1.7%, 2.3% and higher, respectively.

In the FTSE 250, Hilton Food lost 5.5% after it reported its annual profit fell, as it announced the appointment of its new chief executive officer.

Hilton Food appointed Steve Murrells as CEO, with effect on July 3.

Murrells will be replacing Phillip Heffer, who is stepping down after five years in this role. Hilton Food said Heffer will remain with the company as co-founder and advisor to its Foods board.

The food packaging business said its revenue for the year ended January 1 grew by 17% to GBP3.85 billion from GBP3.30 billion the year prior.

This was primarily driven by higher raw material prices and volume growth following Hilton Food's recent acquisition of Foppen, the company said.

Meanwhile, its pretax profit fell by 38% to GBP29.6 million from GBP47.4 million.

This was attributed to challenges in the company's UK Seafood business, as a recovery from inflation took longer than expected, Hilton Food explained.

At the other end of the FTSE 250, Direct Line rose 6.2% after Citigroup raised the insurer to 'buy' from 'sell' with a price target of 188 pence. The stock closed at 152.40p.

Elsewhere in London, Topps Tiles rose 6.9% after it delivered a "record" period in the first half of its financial year, ended April 1.

Revenue climbed 9.5% year-on-year to GBP130.5 million from GBP119.2 million. Topps Tiles said the strong revenue performance reflected the "strength of brands, the execution of our strategy and encouraging domestic market conditions".

The tile seller also noted that about GBP9.0 million of revenue growth is related to the acquisition of Pro Tiler Tools and the launch of Tile Warehouse in 2022.

Chief Executive Rob Parker said: "The economic outlook remains uncertain but early signs of easing supply chain pressures, allied to the group's strong balance sheet, world class customer service, specialist expertise and growth strategy give us confidence in our ability to drive value for all stakeholders over the medium term."

On AIM, Fulham Shore soared 32% after it agreed to be taken over by Tokyo-listed food company Toridoll.

Toridoll will pay 14.15 pence per share, a 35% premium to Fulham Shore's Tuesday closing price of 10.50p. The deal gives the owner of restaurant chains Franco Manca and The Real Greek an equity value of GBP93.4 million.

In European equities on Wednesday, the CAC 40 in Paris ended down 0.4%, while the DAX 40 in Frankfurt ended down 0.5%.

The eurozone private sector economy expanded at the strongest pace since May 2022, driven by the services arm.

The seasonally adjusted S&P Global eurozone composite purchasing managers' index rose to 53.7 points in March, from 52.0 points in February.

This marks the highest level since May 2022, and a third successive month above the critical 50.0 threshold that splits growth from contraction.

The euro stood at USD1.0919 at the European equities close on Wednesday, lower against USD1.0957 at the same time on Tuesday.

Stocks in New York were mostly lower at the London equities close, with the Dow Jones Industrial Average up 0.1%, the S&P 500 index down 0.5%, and the Nasdaq Composite down 1.3%.

US service sector firms recorded faster growth in business activity during March, according to the latest data from S&P Global.

The seasonally adjusted final S&P Global US services PMI posted 52.6 in March, up from 50.6 in February. An earlier flash estimate had expected a reading of 53.8.

S&P Global said the rise in output was the sharpest since June. Firms attributed this to stronger client demand, a renewed rise in orders and the acquisition of new customers.

However, despite the stronger demand conditions, business confidence was below the series average and dipped from February amid inflation concerns.

"Business activity across the service sector expanded at a faster pace in March, as a return to new order growth offered a tonic to the US economy, which saw the fastest rise in private sector output since last June," said Sian Jones, senior economist at S&P Global Market Intelligence.

Against the yen, the dollar was trading at JPY130.94, lower compared to JPY131.83 late Tuesday.

Brent oil was quoted at USD84.48 a barrel at the London equities close on Wednesday, down slightly from USD84.52 late Tuesday. Gold was quoted at USD2,021.30 an ounce, higher against USD2,016.62.

In Thursday's UK corporate calendar, there are trading statements from Ferrexpo and Robert Walters.

In the economic calendar, the Halifax UK house price index will be published at 0700 BST before a UK construction PMI print at 0930 BST.

The US weekly unemployment insurance claims will be released at 1330 BST.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
25 Mar 2024 08:40

TOP NEWS: AstraZeneca wins US approval for rare nervous system disease

(Alliance News) - AstraZeneca PLC on Monday said its Ultomiris treatment has been approved by the US Food & Drug Administration as the first and only long-acting C5 complement inhibitor to treat neuromyelitis optica spectrum disorder in adults.

Read more
25 Mar 2024 07:59

LONDON BRIEFING: AstraZeneca wins US approval, Kingfisher profit down

(Alliance News) - London's FTSE 100 is set to open lower on Monday, giving back some of last week's progress, when equities were boosted by hope of interest rate cuts.

Read more
25 Mar 2024 07:23

AstraZeneca gets FDA approval for Ultomiris treatment

(Sharecast News) - AstraZeneca has announced that its autoimmune disease treatment Ultomiris has been given the green light by US regulators.

Read more
21 Mar 2024 16:43

AstraZeneca's Tagrisso successful in treating lung cancer

(Alliance News) - AstraZeneca PLC on Thursday reported positive findings following a phase III trial of its lung cancer Tagrisso treatment.

Read more
19 Mar 2024 08:56

TOP NEWS: AstraZeneca to buy Fusion in deal worth over USD2 billion

(Alliance News) - AstraZeneca PLC on Tuesday said it will buy Fusion Pharmaceuticals Inc, a Canada-based clinical-stage biopharmaceutical company developing "next-generation" radioconjugates.

Read more
19 Mar 2024 07:05

AstraZeneca to buy US-listed Fusion Phrama for $2bn

(Sharecast News) - AstraZeneca said it had agreed to buy biopharmaceutical company Fusion Pharmaceuticals for up to $2bn.

Read more
18 Mar 2024 16:09

UK dividends calendar - next 7 days

Tuesday 19 March 
Jarvis Securities PLCdividend payment date
Wednesday 20 March 
Virgin Money UK PLCdividend payment date
Thursday 21 March 
abrdn Asia Focus PLCdividend payment date
abrdn Private Equity Opportunities Trust PLCex-dividend payment date
AIB Group PLCex-dividend payment date
Beazley PLCex-dividend payment date
BlackRock World Mining Trust PLCex-dividend payment date
British American Tobacco PLCex-dividend payment date
Chemring Group PLCex-dividend payment date
CLS Holdings PLCex-dividend payment date
Conduit Holdings Ltdex-dividend payment date
Craneware PLCex-dividend payment date
Crest Nicholson Holdings PLCex-dividend payment date
Diverse Income Trust PLCex-dividend payment date
Fonix Mobile PLCex-dividend payment date
FW Thorpe PLCex-dividend payment date
Glanbia PLCex-dividend payment date
GlobalData PLCex-dividend payment date
Globalworth Real Estate Investments Ltdex-dividend payment date
Goodwin PLCex-dividend payment date
Gore Street Energy Storage Fund PLCex-dividend payment date
Hargreaves Services PLCex-dividend payment date
HgCapital Trust PLCex-dividend payment date
Hikma Pharmaceuticals PLCex-dividend payment date
Jardine Matheson Holdings LDex-dividend payment date
London Finance & Investment Group PLCex-dividend payment date
Maven Income & Growth VCT 3 PLCex-dividend payment date
Maven Income & Growth VCT 5 PLCex-dividend payment date
MTI Wireless Edge Ltdex-dividend payment date
Nichols PLCex-dividend payment date
NWF Group PLCex-dividend payment date
Palace Capital PLCex-dividend payment date
Pearson PLCex-dividend payment date
Pembroke VCT B PLCex-dividend payment date
Primorus Investments PLCex-dividend payment date
Schroders PLCex-dividend payment date
Triple Point Energy Transition PLCex-dividend payment date
Tristel PLCex-dividend payment date
VPC Specialty Lending Investments PLCdividend payment date
Friday 22 March 
easyJet PLCdividend payment date
FRP Advisory Group PLCdividend payment date
Gulf Investment Fund PLCdividend payment date
Henderson Opportunities Trust PLCdividend payment date
Hercules Site Services PLCdividend payment date
Impax Asset Management Group PLCdividend payment date
JLEN Environmental Assets Group Ltddividend payment date
JPMorgan Multi-Asset Growth & Income PLCdividend payment date
Mattioli Woods PLCdividend payment date
Mobeus Income & Growth 2 VCT PLCdividend payment date
Mobeus Income & Growth 4 VCT PLCdividend payment date
Ramsdens Holdings PLCdividend payment date
Riverstone Credit Opportunities Income PLCdividend payment date
Ruffer Investment Co Ltddividend payment date
Samuel Heath & Sons PLCdividend payment date
Troy Income & Growth Trust PLCdividend payment date
Unilever PLCdividend payment date
Monday 25 March 
AstraZeneca PLCdividend payment date
Endeavour Mining PLCdividend payment date
Mountview Estates PLCdividend payment date
Shell PLCdividend payment date
  
Comments and questions to newsroom@alliancenews.com
  
A full 14-day events calendar is provided each day with a subscription to Alliance News UK Professional.
  
Copyright 2024 Alliance News Ltd. All Rights Reserved.

Read more
18 Mar 2024 14:08

AstraZenca hails Imfinzi and Lynparza results on endometrial cancer

(Alliance News) - AstraZeneca PLC on Monday reported positive findings following the analysis of results from a phase III probe of its Imfinzi and Lynparza cancer treatments.

Read more
14 Mar 2024 10:01

TOP NEWS: AstraZeneca buys France's Amolyt Pharma for USD1 billion

(Alliance News) - AstraZeneca PLC on Thursday said it has struck a deal to acquire Amolyt Pharma SAS, strengthening its late-stage rare disease pipeline.

Read more
14 Mar 2024 07:52

LONDON BRIEFING: Astra makes USD1.05 billion buy; Halma backs outlook

(Alliance News) - London's FTSE 100 is set to tread water after the opening bell sounds on Thursday, as investors look to a batch of US data to come in the early afternoon.

Read more
14 Mar 2024 07:16

AstraZeneca snaps up rare disease specialist Amolyt for $1.05bn

(Sharecast News) - Biopharma giant AstraZeneca has announced the acquisition of French biotech firm Amolyt Pharma for up to $1.05bn to beef up its late-stage rare disease pipeline.

Read more
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.